Serological determinants of COVID-19.

Annalisa Noce, Maria Luisa Santoro, Giulia Marrone, Cartesio D'Agostini, Ivano Amelio, Andrea Duggento, Manfredi Tesauro, Nicola Di Daniele
Author Information
  1. Annalisa Noce: UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, via Montpellier 1, 00133, Rome, Italy. annalisa.noce@uniroma2.it. ORCID
  2. Maria Luisa Santoro: Laboratory Pathologist Director of Artemisia Lab - Alessandria, Via Piave, 76 00187, Rome, Italy.
  3. Giulia Marrone: UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, via Montpellier 1, 00133, Rome, Italy.
  4. Cartesio D'Agostini: Department of Experimental Medicine, University of Rome Tor Vergata, via Montpellier 1, 00133, Rome, Italy.
  5. Ivano Amelio: Department of Experimental Medicine, University of Rome Tor Vergata, via Montpellier 1, 00133, Rome, Italy.
  6. Andrea Duggento: Department of Biomedicine and Prevention, University of Rome Tor Vergata, via Montpellier 1, 00133, Rome, Italy.
  7. Manfredi Tesauro: UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, via Montpellier 1, 00133, Rome, Italy. mtesauro@tiscali.it.
  8. Nicola Di Daniele: UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, via Montpellier 1, 00133, Rome, Italy.

Abstract

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection spreaded rapidly worldwide, as far as it has become a global pandemic. Therefore, the introduction of serological tests for determination of IgM and IgG antibodies has become the main diagnostic tool, useful for tracking the spread of the virus and for consequently allowing its containment. In our study we compared point of care test (POCT) lateral flow immunoassay (FIA) vs automated chemiluminescent immunoassay (CLIA), in order to assess their specificity and sensibility for COVID-19 antibodies detection.
RESULTS: We find that different specificities and sensitivities for IgM and IgG tests. Notably IgM POCT FIA method vs CLIA method (gold standard) has a low sensitivity (0.526), while IgG POCT FIA method vs CLIA method (gold standard) test has a much higher sensitivity (0.937); further, with respect of IgG, FIA and CLIA could arguably provide equivalent information.
CONCLUSIONS: FIA method could be helpful in assessing in short time, the possible contagiousness of subjects that for work reasons cannot guarantee "social distancing".

Keywords

References

  1. Biol Direct. 2018 Oct 12;13(1):22 [PMID: 30621760]
  2. Acta Otorhinolaryngol Ital. 2020 Jun;40(3):164-172 [PMID: 32773777]
  3. Neuropsychologia. 1988;26(1):161-6 [PMID: 3242500]
  4. JAMA. 2020 Mar 17;323(11):1061-1069 [PMID: 32031570]
  5. N Engl J Med. 2020 Apr 30;382(18):1708-1720 [PMID: 32109013]
  6. Nat Med. 2020 Jun;26(6):845-848 [PMID: 32350462]
  7. Nat Rev Dis Primers. 2020 Aug 27;6(1):71 [PMID: 32855422]
  8. N Engl J Med. 2020 Sep 10;383(11):1078-1080 [PMID: 32905684]
  9. Biol Direct. 2018 Oct 26;13(1):24 [PMID: 30621755]
  10. Laryngoscope. 2020 Jul;130(7):1787 [PMID: 32237238]
  11. Biol Direct. 2019 Jul 24;14(1):11 [PMID: 31340852]
  12. Cell Death Differ. 2020 May;27(5):1451-1454 [PMID: 32205856]
  13. J Clin Microbiol. 2020 Apr 23;58(5): [PMID: 32102856]
  14. Nature. 2020 Mar;579(7798):270-273 [PMID: 32015507]
  15. Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076 [PMID: 32172228]
  16. Lancet Respir Med. 2020 Apr;8(4):420-422 [PMID: 32085846]
  17. JAMA. 2020 Feb 25;323(8):709-710 [PMID: 31999307]
  18. JAMA Cardiol. 2020 Oct 1;5(10):1085-1086 [PMID: 32402054]
  19. Nat Commun. 2021 Dec 3;12(1):7063 [PMID: 34862373]
  20. Biol Direct. 2019 Aug 16;14(1):13 [PMID: 31420049]
  21. Clin Infect Dis. 2020 Jul 28;71(15):778-785 [PMID: 32198501]
  22. Diagnostics (Basel). 2020 Apr 05;10(4): [PMID: 32260471]
  23. Korean J Radiol. 2020 May;21(5):623-624 [PMID: 32207257]
  24. Clin Chem Lab Med. 2020 Jun 25;58(7):1081-1088 [PMID: 32301749]
  25. Biol Direct. 2019 Nov 13;14(1):20 [PMID: 31722729]
  26. Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028 [PMID: 32286245]
  27. Biol Direct. 2019 Nov 27;14(1):23 [PMID: 31775867]
  28. J Med Virol. 2020 Sep;92(9):1518-1524 [PMID: 32104917]
  29. Br J Sports Med. 2020 Oct;54(19):1132-1133 [PMID: 32381502]
  30. Nutrients. 2019 May 14;11(5): [PMID: 31091761]
  31. Lancet. 2020 Feb 15;395(10223):497-506 [PMID: 31986264]
  32. Biol Direct. 2019 Nov 21;14(1):22 [PMID: 31752974]
  33. Infect Chemother. 2020 Jun;52(2):154-164 [PMID: 32537961]
  34. Curr Med Chem. 2021;28(2):284-307 [PMID: 32900341]
  35. Biol Direct. 2019 Feb 26;14(1):5 [PMID: 30808378]
  36. BMJ. 2020 Jul 1;370:m2516 [PMID: 32611558]
  37. Biol Direct. 2019 Aug 20;14(1):15 [PMID: 31429791]
  38. Clin Chim Acta. 2020 Jun;505:190-191 [PMID: 32145275]
  39. JAMA. 2020 Jun 9;323(22):2249-2251 [PMID: 32374370]
  40. BMJ. 2020 Apr 8;369:m1403 [PMID: 32269032]
  41. Clin Infect Dis. 2020 Dec 17;71(10):2669-2678 [PMID: 32497191]
  42. JAMA. 2020 May 12;323(18):1824-1836 [PMID: 32282022]
  43. Cell Death Dis. 2020 Jul 8;11(7):512 [PMID: 32641681]
  44. J Thorac Oncol. 2020 May;15(5):700-704 [PMID: 32114094]
  45. Clin Med (Lond). 2020 Jul;20(4):e114-e119 [PMID: 32620590]
  46. Biol Direct. 2019 Apr 29;14(1):8 [PMID: 31036036]
  47. Cell. 2020 Apr 16;181(2):271-280.e8 [PMID: 32142651]
  48. Trends Biotechnol. 2021 Mar;39(3):311-321 [PMID: 32861547]
  49. Infect Agent Cancer. 2020 Aug 31;15:53 [PMID: 32884579]
  50. Nutrients. 2019 May 15;11(5): [PMID: 31096558]
  51. J Infect. 2020 Jul;81(1):e28-e32 [PMID: 32283141]
  52. J Virol. 2020 Aug 17;94(17): [PMID: 32571797]

MeSH Term

Amino Acid Sequence
COVID-19
Coronavirus Infections
Female
Humans
Immunoassay
Immunoglobulin M
Luminescent Measurements
Male
Middle Aged
Pandemics
Pneumonia, Viral
Protein Domains
Serologic Tests
Spike Glycoprotein, Coronavirus

Chemicals

Immunoglobulin M
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2

Word Cloud

Created with Highcharts 10.0.0FIAmethodIgGimmunoassayCLIAtestsIgMPOCTvsCOVID-19SARS-CoV-2becomeantibodiescaretestflowchemiluminescentdetectiongoldstandardsensitivity0SerologicalBACKGROUND:Severeacuterespiratorysyndromecoronavirus2infectionspreadedrapidlyworldwidefarglobalpandemicThereforeintroductionserologicaldeterminationmaindiagnostictoolusefultrackingspreadvirusconsequentlyallowingcontainmentstudycomparedpointlateralautomatedorderassessspecificitysensibilityRESULTS:finddifferentspecificitiessensitivitiesNotablylow526muchhigher937respectarguablyprovideequivalentinformationCONCLUSIONS:helpfulassessingshorttimepossiblecontagiousnesssubjectsworkreasonsguarantee"socialdistancing"determinantsAutomatedLaboratoryLateralPoint

Similar Articles

Cited By